Bcl-2 allows effector and memory CD8+ T cells to tolerate higher expression of Bim
- PMID: 21451108
- PMCID: PMC4222684
- DOI: 10.4049/jimmunol.1100102
Bcl-2 allows effector and memory CD8+ T cells to tolerate higher expression of Bim
Abstract
As acute infections resolve, most effector CD8(+) T cells die, whereas some persist and become memory T cells. Recent work showed that subsets of effector CD8(+) T cells, identified by reciprocal expression of killer cell lectin-like receptor G1 (KLRG1) and CD127, have different lifespans. Similar to previous reports, we found that effector CD8(+) T cells reported to have a longer lifespan (i.e., KLRG1(low)CD127(high)) have increased levels of Bcl-2 compared with their shorter-lived KLRG1(high)CD127(low) counterparts. Surprisingly, we found that these effector KLRG1(low)CD127(high) CD8(+) T cells also had increased levels of Bim compared with KLRG1(high)CD127(low) cells. Similar effects were observed in memory cells, in which CD8(+) central memory T cells expressed higher levels of Bim and Bcl-2 than did CD8(+) effector memory T cells. Using both pharmacologic and genetic approaches, we found that survival of both subsets of effector and memory CD8(+) T cells required Bcl-2 to combat the proapoptotic activity of Bim. Interestingly, inhibition or absence of Bcl-2 led to significantly decreased expression of Bim in surviving effector and memory T cells. In addition, manipulation of Bcl-2 levels by IL-7 or IL-15 also affected expression of Bim in effector CD8(+) T cells. Finally, we found that Bim levels were significantly increased in effector CD8(+) T cells lacking Bax and Bak. Together, these data indicate that cells having the highest levels of Bim are selected against during contraction of the response and that Bcl-2 determines the level of Bim that effector and memory T cells can tolerate.
Figures






Similar articles
-
Bim mediates apoptosis of CD127(lo) effector T cells and limits T cell memory.Eur J Immunol. 2006 Jul;36(7):1694-706. doi: 10.1002/eji.200635897. Eur J Immunol. 2006. PMID: 16761315 Free PMC article.
-
STAT5 is critical to maintain effector CD8+ T cell responses.J Immunol. 2010 Aug 15;185(4):2116-24. doi: 10.4049/jimmunol.1000842. Epub 2010 Jul 19. J Immunol. 2010. PMID: 20644163 Free PMC article.
-
Expression of KLRG1 and CD127 defines distinct CD8+ subsets that differentially impact patient outcome in follicular lymphoma.J Immunother Cancer. 2021 Jul;9(7):e002662. doi: 10.1136/jitc-2021-002662. J Immunother Cancer. 2021. PMID: 34226281 Free PMC article.
-
Contracting the 'mus cells'--does down-sizing suit us for diving into the memory pool?Immunol Rev. 2010 Jul;236:54-67. doi: 10.1111/j.1600-065X.2010.00920.x. Immunol Rev. 2010. PMID: 20636808 Free PMC article. Review.
-
Surviving the crash: transitioning from effector to memory CD8+ T cell.Semin Immunol. 2009 Apr;21(2):92-8. doi: 10.1016/j.smim.2009.02.002. Epub 2009 Mar 6. Semin Immunol. 2009. PMID: 19269192 Free PMC article. Review.
Cited by
-
PP2A-dependent control of transcriptionally active FOXO3a in CD8(+) central memory lymphocyte survival requires p47(phox).Cell Death Dis. 2012 Aug 23;3(8):e375. doi: 10.1038/cddis.2012.118. Cell Death Dis. 2012. PMID: 22914323 Free PMC article.
-
IL-15 Fosters Age-Driven Regulatory T Cell Accrual in the Face of Declining IL-2 Levels.Front Immunol. 2013 Jun 24;4:161. doi: 10.3389/fimmu.2013.00161. eCollection 2013. Front Immunol. 2013. PMID: 23805138 Free PMC article.
-
No time to die: Epigenetic regulation of natural killer cell survival.Immunol Rev. 2024 May;323(1):61-79. doi: 10.1111/imr.13314. Epub 2024 Mar 1. Immunol Rev. 2024. PMID: 38426615 Review.
-
EZH2 Inhibition Compromises α4-1BB-Mediated Antitumor Efficacy by Reducing the Survival and Effector Programming of CD8+ T Cells.Front Immunol. 2021 Nov 24;12:770080. doi: 10.3389/fimmu.2021.770080. eCollection 2021. Front Immunol. 2021. PMID: 34925340 Free PMC article.
-
Deciphering Natural Killer Cell Homeostasis.Front Immunol. 2020 May 12;11:812. doi: 10.3389/fimmu.2020.00812. eCollection 2020. Front Immunol. 2020. PMID: 32477340 Free PMC article. Review.
References
-
- Gillette-Ferguson I, Sidman CL. A specific intercellular pathway of apoptotic cell death is defective in the mature peripheral T cells of autoimmune lpr and gld mice. Eur J Immunol. 1994;24:1181–1185. - PubMed
-
- Mogil RJ, Radvanyi L, Gonzalez-Quintial R, Miller R, Mills G, Theofilopoulos AN, Green DR. Fas (CD95) participates in peripheral T cell deletion and associated apoptosis in vivo. Int Immunol. 1995;7:1451–1458. - PubMed
-
- Singer GG, Abbas AK. The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity. 1994;1:365–371. - PubMed
-
- Brunner T, Mogil RJ, LaFace D, Yoo NJ, Mahboubi A, Echeverri F, Martin SJ, Force WR, Lynch DH, Ware CF, et al. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature. 1995;373:441–444. - PubMed
-
- Dhein J, Walczak H, Bäumler C, Debatin KM, Krammer PH. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95) Nature. 1995;373:438–441. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials